Search results
Results from the WOW.Com Content Network
(Reuters) -Novocure's therapy met the main goal of a late-stage trial of slowing the progression of cancer to the brain in patients with a type of lung cancer, the company said on Wednesday ...
On Monday, NovoCure Ltd (NASDAQ:NVCR) and Zai Lab Limited (NASDAQ:ZLAB) revealed topline data from the Phase 3 PANOVA-3 trial of Tumor-Treating Fields (TTFields) therapy concomitantly with ...
The life science industry recently gave folks diagnosed with pancreatic cancer the best news this group has received in a very long time. Novocure (NASDAQ: NVCR) and its international partner Zai ...
Novocure plans to submit marketing application to the U.S. Food and Drug Administration in the second half of 2023 based on the data. Novocure's shares fell 34.2% to a more than three-year low of ...
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
On Tuesday, the FDA approved NovoCure’s (NASDAQ:NVCR) Optune Lua for concurrent use with PD-1/PD-L1 inhibitors or docetaxel for adult patients with metastatic non-small cell lung cancer (mNSCLC ...
Fox News. Travis, Jason Kelce give blunt take on Christmas movie Taylor Swift, Kylie Kelce have… Entertainment. USA TODAY.
Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL